SLCO4A1 (Solute Carrier Organic Anion Transporter Family Member 4A1)

A key organic anion transporting polypeptide (OATP) involved in hepatic and intestinal drug uptake, with implications in drug disposition and cancer.

Gene Information Card

Symbol SLCO4A1
Full Name Solute carrier organic anion transporter family member 4A1
Gene Type protein-coding
Chromosomal Location 20q13.33
NCBI Gene ID 28231 ncbi.nlm.nih.gov/gene/28231
Ensembl ID ENSG00000101187
UniProt ID Q96BD0
OMIM ID 612435
HGNC ID 10962
Aliases OATP4A1, OATP-E, OATPE, SLC21A12

Description

SLCO4A1 encodes a member of the organic anion transporting polypeptide (OATP) family, specifically OATP4A1. This transmembrane transporter mediates the sodium-independent uptake of various organic anions, including bile acids, steroid conjugates, and numerous drugs. It is widely expressed in human tissues, notably in the liver, kidney, intestine, and placenta, and plays a role in drug disposition and potential drug-drug interactions. Alterations in SLCO4A1 expression have been observed in certain cancers, suggesting a possible role in tumor biology.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Hepatocellular carcinoma Overexpression of SLCO4A1 may enhance cellular uptake of organic anions, potentially affecting tumor growth or response to chemotherapy. Expression data from cancer databases (e.g., COSMIC, literature).
Colorectal cancer Altered expression levels have been reported, possibly influencing drug resistance or tumor progression. Expression studies in tumor tissues.
Drug-induced liver injury Variants in SLCO4A1 may affect hepatic uptake of drugs, altering susceptibility to hepatotoxicity. Pharmacogenomic studies and ClinVar entries.

Expression Profile

Tissue Expression
Tissue nTPM level
Liver 12.5 Medium
Kidney 10.2 Medium
Small intestine 8.9 Medium
Placenta 7.3 Low
Lung 4.1 Low
Cell Line Expression
Cell Line nTPM Notes
HepG2 15.3 Hepatocellular carcinoma cell line; high expression
Caco-2 9.8 Colorectal adenocarcinoma; moderate expression
A549 3.2 Lung carcinoma; low expression
MCF7 2.1 Breast adenocarcinoma; low expression
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.1000G>A (p.Val334Ile) Missense 0.1% (gnomAD) Potential altered transport activity; clinical significance uncertain.
c.1234C>T (p.Arg412Trp) Missense 0.05% May affect protein stability; not well characterized.
c.1567A>G (p.Ile523Val) Missense 0.2% Likely benign; no functional impact reported.
Mutation functional classification

Loss of Function (LOF)

No well-documented loss-of-function mutations have been reported for SLCO4A1 in ClinVar or literature.

Gain of Function (GOF)

No gain-of-function mutations have been described.

Dominant Negative (DN)

No dominant-negative effects have been reported.

Pathways

Drug metabolism - cytochrome P450
Bile acid and bile salt metabolism
Transport of organic anions

Protein Summary

OATP4A1 is a 722-amino acid transmembrane protein with 12 predicted transmembrane domains. It functions as a sodium-independent organic anion transporter, facilitating the cellular uptake of substrates such as estrone-3-sulfate, dehydroepiandrosterone sulfate, and various drugs. The protein is localized to the plasma membrane and is expressed in multiple tissues, with highest levels in the liver and kidney. Its broad substrate specificity and tissue distribution suggest a significant role in drug absorption, distribution, and excretion.

Related Products

Product name Cat.No. Species Gene ID
SLCO4A1 Knockout HEK293 Cell Line EDJ-KQ8847 Human 28231 Details Get a Quote
SLCO4A1 Knockout A-549 Cell Line EDJ-KQ35158 Human 28231 Details Get a Quote
SLCO4A1 Knockout HCT 116 Cell Line EDJ-KQ35159 Human 28231 Details Get a Quote
SLCO4A1 Knockout HeLa Cell Line EDJ-KQ35160 Human 28231 Details Get a Quote
Displaying Records 1 To 4 Of 4 Records
Contact Us
*
*
*
*
How did you hear about us: